Botulinum Toxin Treatment of Notalgia Paresthetica—A Critical Review and Update
Toxins · 2026
DOI: 10.3390/toxins18010050 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Toxins, 2026. Verfasst von Ava Grace Tohidian und 2 weiteren Autor:innen. Beteiligte Einrichtung: Royal College of Surgeons, School of Medicine, D02 YN77 Dublin, Ireland. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Paresthesia, Pruritus. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Notalgia paresthetica is a condition characterized by pruritus and pain in the upper back, often associated with skin discoloration in the same area. Through Medline, Google Scholar, and Scopus search engines, we identified reports of eight clinical studies (published up to 1 December 2025) on the subject of botulinum neurotoxin therapy for Notalgia Paresthetica (NP). Only one of the eight studies was double-blind and placebo-controlled. The search strategy included only articles published in English and Spanish, and articles providing basic information such as the type of study, type and dose of the toxin, and results of the treatment. Articles not in English or Spanish, review articles, and articles failing basic information were excluded. A total of 34 patients were found across all studies. The injected toxin in the open-label studies was onabotulinumtoxin-A (Botox), whereas in the blinded study, the investigators used incobotulinumtoxinA (Xeomin). All open-label studies reported improvement in pruritus, and some reported improvement in pain, whereas the blinded study failed to do so. The possible reasons for this discrepancy between the blinded and the open-label studies are discussed. There is a need for double-blind, placebo-controlled studies with a larger number of patients, preferably using the same neurotoxin that has suggested efficacy in the open-label studies. The novelty of this review is that it represents a comprehensive and critical literature assessment on this topic and that it includes data not present in the previous reviews of this subject.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Royal College of Surgeons, School of Medicine, D02 YN77 Dublin, Ireland.
- Glenn Biggs Institute, University of Texas Health San Antonio, San Antonio, TX 78229, USA.
- Department of Neurology, Yale University School of Medicine, New Haven, CT 06519, USA.
ORCID-Profile: Ava Grace Tohidian, Bahman Jabbari
Zitieren
APA
Tohidian, A. G., Etemadmoghadam, S., & Jabbari, B. (2026). Botulinum Toxin Treatment of Notalgia Paresthetica—A Critical Review and Update. Toxins. https://doi.org/10.3390/toxins18010050
Vancouver
Tohidian AG, Etemadmoghadam S, Jabbari B. Botulinum Toxin Treatment of Notalgia Paresthetica—A Critical Review and Update. Toxins. 2026. doi:10.3390/toxins18010050
BibTeX
@article{Tohidian2026,
author = {Tohidian, Ava Grace and Etemadmoghadam, Shahroo and Jabbari, Bahman},
title = {Botulinum Toxin Treatment of Notalgia Paresthetica—A Critical Review and Update},
journal = {Toxins},
year = {2026},
doi = {10.3390/toxins18010050}
}
EUVIMED